Pricing Log in Create free account

enGene Therapeutics Inc (ENGN) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

enGene Therapeutics Inc and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. enGene Therapeutics Inc and Tonix Pharmaceuticals Holding Corp. are of similar size ($114.6M and $110.1M). enGene Therapeutics Inc has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 14 metrics below, enGene Therapeutics Inc leads on 10 and Tonix Pharmaceuticals Holding Corp. on 4.

Valuation

Metric ENGN TNXP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.45 9.71
P/B 0.51 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.91 0.42 0.64
EV/Sales n/m (2.35) 9.21
Earnings yield (123.72%) (219.31%) (33.15%)
Free cash flow yield (89.30%) (157.36%) (25.50%)

Profitability

Metric ENGN TNXP Biotechnology median
Gross margin — 83.83% 65.16%
Operating margin 0.00% (568.43%) 0.00%
Net margin 0.00% (548.64%) 0.00%
Free cash flow margin 0.00% (543.29%) 0.00%
Return on equity (60.50%) (81.82%) (56.36%)
Return on assets (48.84%) (72.34%) (48.04%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric ENGN TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 6.02%
EPS growth (last fiscal year) (56.85%) 91.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENGN TNXP Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 10.21 6.61 4.72
Net debt to EBITDA 1.42 1.68 0.96

Dividend

Metric ENGN TNXP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENGN TNXP Biotechnology median
Market cap 114.60m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack